SCHEMBL29789643

SCHEMBL29789643

Cn1ccnc1-c1cccc2c1CCC(C)(C)N2

nearest known ligand 0.41

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ KDM1A O60341 5/20 0.41
▸ ADRA1D P25100 1/20 0.37
▸ ADRA1A P35348 1/20 0.37
▸ ADRA1B P35368 1/20 0.37
▸ BRD4 O60885 1/20 0.37
▸ HTR2C P28335 2/20 0.37
▸ HTR2A P28223 1/20 0.37
▸ GRM5 P41594 1/20 0.36
▸ PIM1 P11309 1/20 0.33
▸ PIM2 Q9P1W9 1/20 0.33
▸ MC4R P32245 2/20 0.32
▸ BACE1 P56817 1/20 0.32
▸ BACE2 Q9Y5Z0 1/20 0.32
▸ AR P10275 1/20 0.32
▸ KDM4E B2RXH2 1/20 0.32
▸ CASP1 P29466 1/20 0.32
▸ CASP7 P55210 1/20 0.32
▸ HSD17B10 Q99714 1/20 0.32
▸ L3MBTL1 Q9Y468 1/20 0.32
▸ HCRTR1 O43613 1/20 0.31

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL23123822 1.00 KDM1A (0.41) KDM1AADRA1DADRA1AADRA1BBRD4
SCHEMBL23123988 0.75 ADRA1A (0.41) KDM1AADRA1DADRA1AADRA1BAR
SCHEMBL29789642 0.75 ADRA1A (0.41) KDM1AADRA1DADRA1AADRA1BAR
SCHEMBL29789713 0.72 AR (0.41) AR
SCHEMBL23123752 0.72 AR (0.41) AR
SCHEMBL23123492 0.70 BRD4 (0.38) KDM1AADRA1DADRA1AADRA1BBRD4
SCHEMBL29789762 0.70 BRD4 (0.38) KDM1AADRA1DADRA1AADRA1BBRD4
SCHEMBL24700460 0.69 DRD2 (0.44) KDM1AKDM4EHSD17B10L3MBTL1
SCHEMBL6911325 0.65 HSD11B1 (0.47) ADRA1DADRA1AADRA1BBRD4HTR2C
Hydrochloric Acid SCHEMBL4345829 0.65 BRD4 (0.57) ADRA1DADRA1AADRA1BBRD4HTR2C

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-114901652-A Substituted saturated and unsaturated N-heterocyclic carboxamides and related compounds for the treatment of medical disorders 比亚尔R&D投资股份公司 2022-08-12 — — CN disclosed
EP-4031540-A1 SUBSTITUTED, SATURATED AND UNSATURATED N-HETEROCYCLIC CARBOXAMIDES AND RELATED COMPOUNDS FOR THEIR USE IN THE TREATMENT OF MEDICAL DISORDERS Bial-R&D Investments, S.A. (PT) 2022-07-27 — — EP disclosed
Send feedback